HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


PCPC Focused On Championing Risk-Based, Proportionate Policies Around The Globe In 2022

Executive Summary

The Personal Care Products Council’s senior leadership team sat down with HBW Insight at the end of January to discuss the year ahead, including EU policy movement that could undermine long-standing chemical risk-assessment principles, disrupting international trade and proving infectious in other parts of the world.

You may also be interested in...

Cosmetics Industry In Perplexing Spot: A Trusted Voice, But What Exactly Is The Conversation?

The year 2022 could be a ripe opportunity for industry to inform public opinion amid sweeping policy changes that stand to transform the global cosmetics sector. Consumers may be inclined to listen when business speaks, but that doesn’t mean they’ll like the conversation.

Cosmetics Europe Says EU’s ‘Radical’ Regulatory Drift Sends Concerning Signal To World

The European Commission plans to launch a public consultation soon on its intention to revise the Cosmetic Products Regulation in line with Green Deal objectives and the Chemicals Strategy for Sustainability. Cosmetics Europe is gearing up for a battle to preserve the sector-specific approach embodied in the EU’s “gold standard” cosmetics regulations. Director-General John Chave discusses.

Microplastic Will Test EU’s Green Resolve As Cosmetics Regulatory Revision Looms

Where the European Commission and Member States land in their final deliberations on the proposed microplastic ban could reveal a lot about industry costs deemed acceptable and the level of science considered necessary to regulate cosmetics and other markets in pursuance of Green Deal objectives.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts